Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 390201 - 390220 out of 505060 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Saudi Arabia | (L01CD04) cabazitaxel | JEVTANA 60 mg concentrate and solvent for solution for infusion | 1 Vial, 1,5ml, 60 mg, Intravenous use, Concentrate and solvent for solution for infusion, 60mg , Vial, Concentrate and solvent for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Prostatic Neoplasms | sanofi-aventis / AVENTISPHARMALIMITED |
| Saudi Arabia | (L01CX01) trabectedin | YONDELIS 1 mg powder for concentrate for solution for infusion | 1 Vial, 25ml, 1 mg, Intravenous use, Powder for concentrate for solution for infusion, 1mg , Vial, Powder for concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Ovarian Neoplasms; Sarcoma | PharmaMarS.A / BAXTERONCOLOGY |
| Saudi Arabia | (L01DB01) doxorubicin | DOXORUBICIN 2 MG/ML SOLUTION FOR INFUSION | 1 Vial, 5ml, 2 mg/ml, Intravenous, Intravesical, Concentrate for solution for infusion, 2mg/ml , Vial, Concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
n/a | AccordHealthcareLimited / INTASPHARMACEUTICALSLIMITED |
| Saudi Arabia | (L01DB01) doxorubicin | DOXORUBICIN 2MG-MLVIAL | 1 Vial, 50ml, 2 mg/ml, Intravenous use, Concentrate for solution for infusion, 2mg/ml , Vial, Concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
n/a | EBEWEPHARMA / FarevaUnterachGmbH |
| Saudi Arabia | (L01DB01) doxorubicin | DOXORUBICIN 2MG-MLVIAL | 1 Vial, 25ml, 2 mg/ml, Intravenous use, Concentrate for solution for infusion, 2mg/ml , Vial, Concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
n/a | EBEWEPHARMA / FarevaUnterachGmbH |
| Saudi Arabia | (L01DB01) doxorubicin | DOXORUBICIN 2MG-MLVIAL | 1 Vial, 5ml, 2 mg/ml, Intravenous use, Concentrate for solution for infusion, 2mg/ml , Vial, Concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
n/a | EBEWEPHARMA / FarevaUnterachGmbH |
| Saudi Arabia | (L01DB01) doxorubicin | DOXORUBICIN 2MG/ML SOLUTION FOR INFUSION | 1 Vial, 25ml, 2 mg/ml, Intravenous, Intravesical, Concentrate for solution for infusion, 2mg/ml , Vial, Concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
n/a | AccordHealthcareLimited / INTASPHARMACEUTICALSLIMITED |
| Saudi Arabia | (L01DB01) doxorubicin | Deroxi Liposomal 50 mg per 25 ml | 1 Vial, 25ml, 2 mg/ml, Intravenous use, Solution for injection, 2mg/ml , Vial, Solution for injection | Retail price without vat |
$0-0 |
$0-0 |
n/a | SUDAIRPHARMACOMPANY / NatcoPharmaLimited |
| Saudi Arabia | (L01DB03) epirubicin | Epirubicin “Ebewe” 10mg/5ml | 1 Vial, 5ml, 2 mg/ml, Intravenous use, Concentrate for solution for infusion, 2mg/ml , Vial, Concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
n/a | EBEWEPHARMA / FarevaUnterachGmbH |
| Saudi Arabia | (L01DB03) epirubicin | Epirubicin “Ebewe” 200mg/100ml | 1 Vial, 100ml, 2 mg/ml, Intravenous use, Concentrate for solution for infusion, 2mg/ml , Vial, Concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
n/a | EBEWEPHARMA / FarevaUnterachGmbH |
| Saudi Arabia | (L01DB03) epirubicin | Epirubicin “Ebewe” 50mg/25ml | 1 Vial, 25ml, 2 mg/ml, Intravenous use, Concentrate for solution for infusion, 2mg/ml , Vial, Concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
n/a | EBEWEPHARMA / FarevaUnterachGmbH |
| Saudi Arabia | (L01DB03) epirubicin | FARMARUBICIN 10MG/5ML INJECTION | 1 Vial, 2 mg/ml, Intravenous use, Solution for injection, 2mg/ml , Vial, Solution for injection | Retail price without vat |
$0-0 |
$0-0 |
n/a | PfizerAustraliaPtyLTD / PFIZERPERTHPTYLIMITED |
| Saudi Arabia | (L01DB03) epirubicin | FARMARUBICIN 50MG/25ML VIAL | 1 Vial, 2 mg/ml, Intravenous use, Solution for injection, 2mg/ml , Vial, Solution for injection | Retail price without vat |
$0-0 |
$0-0 |
n/a | PfizerAustraliaPtyLTD / PFIZERPERTHPTYLIMITED |
| Saudi Arabia | (L01DB07) mitoxantrone | MITOXANTRON EBEWE 2MG-1ML SOL. FOR INFU | 1 Vial, 10ml, 2 mg/ml, Intravenous use, Solution, 2mg/ml , Vial, Solution | Retail price without vat |
$0-0 |
$0-0 |
n/a | EBEWEPHARMA / FarevaUnterachGmbH |
| Saudi Arabia | (L01DC01) bleomycin | Bleoez | 1 Vial, 15 U, Intravenous, Intramuscular, Subcutaneous, powder for solution for injection, 15U , Vial, powder for solution for injection | Retail price without vat |
$0-0 |
$0-0 |
n/a | KoreaUnitedPharm.Inc / KoreaUnitedPharm.Inc |
| Saudi Arabia | (L01DC01) bleomycin | Bleomycin Venus | 1 Vial, 15 USP Units, Intramuscular and intravenous use, Powder for solution for injection/infusion, 15USP Units , Vial, Powder for solution for injection/infusion | Retail price without vat |
$0-0 |
$0-0 |
n/a | VENUSREMEDIESLIMITED / VENUSREMEDIESLIMITED |
| Saudi Arabia | (L01EA02) dasatinib (adm: O) | SPRYCEL 20MG F.C. TABLETS | 60 Bottle, 20 mg, Oral use, Film-coated tablet, 20mg , Bottle, Film-coated tablet | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myelogenous, Chronic, BCR-ABL Positive | BRISTOL-MYERSSQUIBB / AstraZenecaPharmaceuticalsLP |
| Saudi Arabia | (L01EA02) dasatinib (adm: O) | SPRYCEL 50MG F.C. TABLETS | 60 Bottle, 50 mg, Oral use, Film-coated tablet, 50mg , Bottle, Film-coated tablet | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myelogenous, Chronic, BCR-ABL Positive | BRISTOL-MYERSSQUIBB / AstraZenecaPharmaceuticalsLP |
| Saudi Arabia | (L01EA02) dasatinib (adm: O) | SPRYCEL 70MG F.C. TABLETS | 60 Bottle, 70 mg, Oral use, Film-coated tablet, 70mg , Bottle, Film-coated tablet | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myelogenous, Chronic, BCR-ABL Positive | BRISTOL-MYERSSQUIBB / AstraZenecaPharmaceuticalsLP |
| Saudi Arabia | (L01EA03) nilotinib (adm: O) | TASIGNA 150MG CAPSULES | 112 Blister, 150 mg, Oral use, Capsule, 150mg , Blister, Capsule | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NOVARTIS / NOVARTIS |
Pages
